Author

S. Delafontaine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

I. Meyts· 2 shared A. A. d. J. Rasheed· 1 shared A. Damerau· 1 shared A. Hombrouck· 1 shared A. Iannuzzo· 1 shared A. Insalaco· 1 shared B. Pillay· 1 shared D. Cassiman· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

I. Meyts

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Autoinflammatory patients with Golgi-trapped CDC42 exhibit intracellular trafficking defects leading to STING hyperactivation

A. Iannuzzo, S. Delafontaine, R. El Masri, R. Tacine, G. Prencipe, M. Nishitani-Isa, R. T. van Wijck, F. Bhuyan, A. A. d. J. Rasheed, S. Coppola, P. L. van Daele, A. Insalaco, R. Goldbach-Mansky, T. Yasumi, M. Tartaglia, , J. Delon

This study identifies Golgi-trapped CDC42 variants causing STING hyperactivation and IFN elevation in autoinflammatory patients.

bioRxiv · Jan 31, 2024 · PreprintImmunology

Human ADA2 deficiency is characterized by the absence of an intracellular hypoglycosylated form of adenosine deaminase 2

L. Ehlers, M. Wouters, A. Hombrouck, B. Pillay, S. Delafontaine, G. Bucciol, M. Baggio, M. Dzhus, E. Frances Rabanal, A. Damerau, J. Neugebauer, F. Ebstein, M. Jacquemyn, L. De Somer, R. Schrijvers, , I. Meyts

The paper identifies an intracellular hypoglycosylated form of ADA2 absent in DADA2 patients, linking its absence to reduced deaminase activity and variant pathogenicity.

bioRxiv · Oct 25, 2023 · PreprintImmunology